Wingspan M003WS0400200Recalls & reported problems
Stryker Corporation · Stent System · Class f · Implant
Data updated Oct 13, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 2
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 04546540722874), received between May 27, 2016 and Jun 9, 2017 — classified as 2 deaths, 1 injury.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem3
Patient problems
- Death2
- Coma1
- Hemorrhage, Cerebral1
- Stroke/CVA1
- Transient Ischemic Attack1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryJun 9, 2017Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE PATIENT UNDERWENT UNEVENTFUL STENTING OF THE PETROUS SEGMENT LOCATED IN THE LEFT INTERNAL CAROTID ARTERY. IT WAS REPORTED THAT FOUR DAYS POST PROCEDURE, THE PATIENT DEVELOPED TRANSIENT ISCHEMIC ATTACK (TIA). NO TREATMENT WAS REQUIRED AND THE EVENT RESOLVED WITHOUT ANY RESIDUAL EFFECTS. THE PATIENT WAS DISCHARGED APPROXIMATELY THREE DAYS LATER ASSESSED HAVING AN MRS OF 1. RELATIONSHIP OF THE DEVICE PERFORMANCE TO THE TIA WAS REPORTED AS UNKNOWN. THE PATIENT'S CURRENT CONDITION WAS REPORTED AS "PRETTY GOOD".
Patient problems: Transient Ischemic Attack
MAUDE report 6631047 ↗DeathFeb 22, 2017Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT A PATIENT WAS PRESENTED IN A LIFE-THREATENING CONDITION WITH A BASILAR THROMBOTIC STROKE AND NEUROLOGICAL DEFICIT. ACCESS TO THE CLOT WAS LIMITED TO THE RIGHT VERTEBRAL ARTERY (VA) THAT PRESENTED A CRITICAL STENOSIS OF THE VA-DISTAL V4 SEGMENT. LEFT VERTEBRAL ARTERY WAS OCCLUDED AND NOT ACCESSIBLE. ANGIOPLASTY WITH A BALLOON CATHETER OF THE STENOSIS OF VA-V4 SEGMENT LED TO DISSECTION RESULTANT IN HEMATOMA AND OCCLUSION. MEDICAL INTERVENTION IN ORDER TO RESTORE BLOOD FLOW THROUGH THE OCCLUDED VA- V4 SEGMENT BY ANGIOPLASTY WAS PERFORMED WITHOUT SUCCESS. THEN, STENTING OF THE VA-V4 SEGMENT WITH A FIRST STENT WAS PERFORMED. HOWEVER, THE DISTAL STENT TINES DID NOT OPEN PROPERLY EVEN WITH ADDITIONAL ANGIOPLASTY PROCEDURE. BLOOD FLOW WAS NOT RESTORED. A SECOND STENT (SUBJECT DEVICE) WAS ATTEMPTED TO BE IMPLANTED BUT COULD NOT BE DEPLOYED BEYOND THE POORLY OPENED DISTAL TINES OF THE FIRST DEPLOYED STENT. ATTEMPTS TO PUSH THE STENT RESULTED IN ACUTE BENDING OF THE HYPOTUBE RENDERING THE STENT UNUSABLE. A THIRD STENT WAS DEPLOYED MORE DISTALLY IN THE BASILAR ARTERY AND OVERLAPPING THE ORIGINAL STENT. THE STENT WAS ONLY PLACED WITH GREAT DIFFICULTY THROUGH THE FIRST STENT
Patient problems: Coma; Death
MAUDE report 6351670 ↗DeathMay 27, 2016Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
FOLLOWING BALLOON ANGIOPLASTY, A STENT (SUBJECT DEVICE) WAS IMPLANTED TO TREAT A 96% STENOSED M1 MIDDLE CEREBRAL ARTERY (MCA) LESION. APPROXIMATELY 6 HOURS POST PROCEDURE, IT WAS NOTED THAT THE PATIENT MENTAL STATUS CHANGED. COMPUTED TOMOGRAPHY (CT) SCAN CONFIRMED THAT A MASSIVE CEREBRAL HEMORRHAGE RESULTED IN A STROKE WITH SUBSEQUENT BRAIN MIDLINE SHIFT OCCURRED, WHICH LED THE FOLLOWING DAY TO THE PATIENT'S DEATH.
Patient problems: Death; Hemorrhage, Cerebral; Stroke/CVA
MAUDE report 5686969 ↗
Other intracranial neurovascular stent devices
- CERENOVUS ENTERPRISE ENF402312Medos International Sàrl · intracranial neurovascular stent1 death90 reports
- PulseRider Aneurysm Neck Reconstruction Device 201-DMedos International Sàrl · Intracranial Neurovascular Stent2 deaths74 reports
- CERENOVUS ENTERPRISE ENF402300Medos International Sàrl · intracranial neurovascular stent2 deaths66 reports
- CERENOVUS ENTERPRISE ENF403012Medos International Sàrl · intracranial neurovascular stent1 death42 reports
- CERENOVUS ENTERPRISE ENF452212Medos International Sàrl · intracranial neurovascular stent41 reports
- CERENOVUS ENTERPRISE ENF401612Medos International Sàrl · intracranial neurovascular stent36 reports
- CERENOVUS ENTERPRISE ENF401600Medos International Sàrl · intracranial neurovascular stent36 reports
- CERENOVUS ENTERPRISE ENF452812Medos International Sàrl · intracranial neurovascular stent31 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 13, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 13, 2026
- Page last rebuilt: Oct 13, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page